Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial

The ProPrems trial, a multi-center, double-blind, placebo-controlled randomized trial, previously reported a 54% reduction in necrotizing enterocolitis (NEC) of Bell stage 2 or more from 4.4 to 2.0% in 1099 infants born before 32 completed weeks' gestation and weighing

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC microbiology 2018-11, Vol.18 (1), p.184-184, Article 184
Hauptverfasser: Plummer, Erica L, Bulach, Dieter M, Murray, Gerald L, Jacobs, Susan E, Tabrizi, Sepehr N, Garland, Suzanne M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The ProPrems trial, a multi-center, double-blind, placebo-controlled randomized trial, previously reported a 54% reduction in necrotizing enterocolitis (NEC) of Bell stage 2 or more from 4.4 to 2.0% in 1099 infants born before 32 completed weeks' gestation and weighing
ISSN:1471-2180
1471-2180
DOI:10.1186/s12866-018-1326-1